We are live on
!
Find out more
RPSM
Royalty Pharma Sub-Manager Portfolio holdings
AUM
$173M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$173M
AUM Growth
+$1.45M
(+0.85%)
Holding
4
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cytokinetics
CYTK
$11.5B
| $64.6M | 37.4% |
980,392
|
|
||
|
BCAX
2
Bicara Therapeutics
BCAX
$1.9B
| $46.7M | 27.02% |
2,388,150
+1,125,000
|
|
||
3
BioCryst Pharmaceuticals
BCRX
$2.66B
| $36.6M | 21.19% |
3,846,154
|
|
||
4
Biohaven
BHVN
$2.34B
| $24.8M | 14.38% |
2,936,507
|
|